Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
The present invention provides a novel method for inhibiting the cyclooxygenase enzyme COX-2. The method is comprised of administering a composition containing a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids to a host in need thereof. The present also includes novel methods for the prevention and treatment of COX-2 mediated diseases and conditions. The method for preventing and treating COX-2 mediated diseases and conditions is comprised of administering to a host in need thereof an effective amount of a composition containing a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids and a pharmaceutically acceptable carrier.
1. A method for reducing joint dysfunction caused by peroxidase free radical initiated joint wear and tear comprising administering to a host in need thereof a therapeutically effective amount of a composition comprising a Free-B-Ring flavonoid extracted from Scutellaria or a composition containing a mixture of Free-B-Ring flavonoids extracted from Scutellaria and a pharmaceutical acceptable carrier; wherein said the composition is administered at a dosage of 0.01 to 200 mg/kg of body weight of said host.
2. The method of claim 1 wherein said Free-B-Ring flavonoid is selected from the group of compounds having the following structure:
wherein
R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H, —OH, OR, a glycoside of a single or a combination of multiple sugars including, aldopentoses, methyl-aldopentoses, aldohexoses, ketohexoses, glucuronides and their chemical derivatives thereof;
wherein
R is an alkyl group having between 1-10 carbon atoms.
3. The method of claim 1 wherein said Scutellaria is selected from the group consisting of Scutellaria baicalensis, Scutellaria lateriflora, Scutellaria radix and Scutellaria orthocalyx.
4. The method of claim 1 wherein said Free-B-Ring flavonoid is isolated from a plant part.
5. The method of claim 4 wherein the Free-B-Ring flavonoid is isolated from a plant part selected from the group consisting of stems, stem barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers, other reproductive organs, leaves and other aerial parts.
6. The method of claim 1 wherein the administration is selected from the group consisting of oral, topical, suppository, intravenous, intradermic, intragaster, intramuscular, intraperitoneal and intravenous.
7. A method for reducing joint pain, immobility, discomfort, stiffness and inflexibility resulting from free radical production by peroxidase comprising administering to a host in need thereof a therapeutically effective amount of a composition comprising a Free-B-Ring flavonoid extracted from Scutellaria or a composition containing a mixture of Free-B-Ring flavonoids extracted from Scutellaria and a pharmaceutical acceptable carrier; wherein said composition is administered at a dosage of 0.01 to 200 mg/kg of body weight of said host.
8. The method of claim 7 wherein said Free-B-Ring flavonoid is selected from the group of compounds having the following structure:
wherein
R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of —H, —OH, OR, a glycoside of a single or a combination of multiple sugars including, aldopentoses, methyl-aldopentoses, aldohexoses, ketohexoses, glucuronides and their chemical derivatives thereof;
wherein
R is an alkyl group having between 1-10 carbon atoms.
9. The method of claim 7 wherein said Scutellaria is selected from the group consisting of Scutellaria baicalensis, Scutellaria lateriflora, Scutellaria radix and Scutellaria orthocalyx.
10. The method of claim 7 wherein said Free-B-Ring flavonoid is isolated from a plant part.
11. The method of claim 10 wherein the Free-B-Ring flavonoid is isolated from a plant part selected from the group consisting of stems, stem barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers, other reproductive organs, leaves and other aerial parts.
12. The method of claim 7 wherein the administration is selected from the group consisting of oral, topical, suppository, intravenous, intradermic, intragaster, intramuscular, intraperitoneal and intravenous.